1
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Controlled release formulations coated with aqueous dispersions of acrylic polymers. Euro Celtique, Steinberg Raskin & Davidson P C, June 17, 1997: US05639476 (615 worldwide citation)

A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disin ...


2
Benjamin Oshlack, Mark Chasin, John J Minogue, Robert F Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 27, 1996: US05549912 (270 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


3
Benjamin Oshlack, Mark Chasin, John Joseph Minogue, Robert Francis Kaiko: Controlled release oxycodone compositions. Euro Celtique, Steinberg Raskin & Davidson P C, August 12, 1997: US05656295 (258 worldwide citation)

A method for substantially reducing the range in daily dosages required to control pain in approximately 90% of patients is disclosed whereby an oral solid controlled release dosage formulation having from about 10 to about 40 mg of oxycodone or a salt thereof is administered to a patient. The formu ...


4
Richard S Sackler, Robert F Kaiko, Paul Goldenheim: Method of treating pain by administering 24 hour oral opioid formulations. Purdue Pharma, Steinberg Raskin & Davidson P C, September 30, 1997: US05672360 (244 worldwide citation)

Patients are treated with 24-hour oral sustained release opioid formulations which, upon administration, provide an initially rapid opioid absorption such that the minimum effective analgesic concentration of the opioid is more quickly achieved. These sustained release opioid formulations include an ...


5
Benjamin Oshlack, Frank Pedi Jr, Mark Chasin: Controlled release formulations coated with aqueous dispersions of acrylic polymers. Euro Celtique, Steinberg Raskin & Davidson P C, December 3, 1996: US05580578 (234 worldwide citation)

A stable solid controlled release formulation having a coating derived from an aqueous dispersion of a hydrophobic acrylic polymer includes a substrate including an active agent selected from the group consisting of a systemically active therapeutic agent, a locally active therapeutic agent, a disin ...


6
Richard Sackler, Paul Goldenheim, Mark Chasin: Prolonged local anesthesia with colchicine. Euro Celtique, Steinberg Raskin & Davidson P C, May 5, 1998: US05747060 (183 worldwide citation)

A formulation for inducing sustained regional local anesthesia in a patient comprising a substrate comprising a local anesthetic and an effective amount of a biocompatible, biodegradable, controlled release material prolonging the release of the local anesthetic from the substrate to obtain a revers ...


7
Pascal Rokegem, Jean Paul F Steib: Rod attachment device for rachidian orthopaedy. Eurosurgical, Steinberg Raskin & Davidson P C, May 20, 1997: US05630817 (165 worldwide citation)

A device for the attachment to a rod (1) of a member (24) such as a screw, a hook or the like, in particular for spinal instrumentation. The device interacts with a smooth rod (1) and comprises an intermediate socket in the shape of a split ring (22) engageable on said rod. A tightening means (23) i ...


8
Benjamin Oshlack, Mark Chasin, Frank Pedi Jr: Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer. Euro Celtique, Steinberg Raskin & Davidson P C, October 28, 1997: US05681585 (152 worldwide citation)

A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature and rel ...


9
Ronald B Miller, Stewart T Leslie, Sandra T A Malkowska, Kevin J Smith, Walter Wimmer, Horst Winkler, Udo Hahn, Derek A Prater: Controlled release formulation. Euro Celtique, Steinberg Raskin & Davidson P C, January 7, 1997: US05591452 (110 worldwide citation)

A controlled release preparation for oral administration contains tramadol, or a pharmaceutically acceptable salt thereof, as active ingredient.


10
Ian R Buxton, Helen Critchley, Stewart T Leslie, Derek A Prater, Ronald B Miller, Sandra T A Malkowska: Pharmaceutical spheroid formulation. Euro Celtique, Steinberg Raskin & Davidson P C, February 11, 1997: US05601845 (105 worldwide citation)

A controlled release composition including spheroid cores of diltiazem. or a pharmaceutically acceptable salt thereof and optionally a spheronizing agent, the cores being coated with a controlled release layer, and a method of manufacturing the same, is disclosed. The spheronizing agent when present ...